Through our test reports and wellness recommendations, customers are empowered to know more about themselves and be informed about potential risks for the future. It allows them to make relevant proactive lifestyle adjustments to enhance their health. GeneLife offers a variety of genetic testing kits ranging from health, personality, diet and nutrition, beauty and skincare, sports and fitness as well as ancestry.
Since our inception, our aim has been to support healthcare providers, medical institutions and universities in their research programs. Providing high quality genetic analysis services, accessible at the most competitive cost in Japan and across Asia, GenesisPro offers a range of professional services including Next Generation Sequencers (NGS), microarray and PCR analysis.
GenesisGaia is a new genomic platform that allows us to use, store and manage genetic data accumulated over the years for research and development (R&D) for clients. By incorporating GenesisGaia, clients can significantly speed up their R&D for drug discovery and in medical and healthcare.
Mar 8, 2021
The partnership covers distribution of direct-to-consumer genetic testing services in the Vietnamese market. The first product to be introduced will be GeneLife Genesis 2.0
Mar 8, 2021
Researchers at Genesis Healthcare Co., Japan's leading genetic testing and research company and Department of Advanced Informatics of Genetic Diseases, Juntendo University, have conducted a joint-research
Mar 1, 2021
ANNOUNCING JAPAN’S FIRST NEW HOME TESTING COVID-19 TESTING KITS USING ENHANCED TECHNOLOGY FOR IMPROVED ACCURACY IN ISOLATING FALSE NEGATIVES OF VARIOUS STRAINS
Jan 26, 2021
Genesis Healthcare Co. today announced the following changes in Representative Director as decided by resolution of the Board of Directors.
Jan 12, 2021
Singapore, January 12, 2021 – Genesis Healthcare Asia Pte. Ltd. announces a partnership with Kalgen Innolab in Indonesia.
Oct 13, 2020
TOKYO, October 12, 2020 -- Genesis Healthcare Co., Japan's leading genetic testing and research company, reveals a research methodology to identify and reduce SARS-CoV-2 (COVID-19) false negatives for RT-PCR tests conducted in Japan.